Last data update: May 06, 2024 . (Total: 1930 publications since 2020)
Records 1-8 (of 8 Records) |
Query Trace: Price AM[original query] |
---|
Effectiveness of Pfizer-BioNTech mRNA Vaccination Against COVID-19 Hospitalization Among Persons Aged 12-18 Years - United States, June-September 2021.
Olson SM , Newhams MM , Halasa NB , Price AM , Boom JA , Sahni LC , Irby K , Walker TC , Schwartz SP , Pannaraj PS , Maddux AB , Bradford TT , Nofziger RA , Boutselis BJ , Cullimore ML , Mack EH , Schuster JE , Gertz SJ , Cvijanovich NZ , Kong M , Cameron MA , Staat MA , Levy ER , Chatani BM , Chiotos K , Zambrano LD , Campbell AP , Patel MM , Randolph AG , Overcoming COVID-19 Investigators . MMWR Morb Mortal Wkly Rep 2021 70 (42) 1483-1488 |
Factors associated with COVID-19 non-vaccination in adolescents hospitalized without COVID-19.
Sahni LC , Price AM , Olson SM , Newhams MM , Pannaraj PS , Maddux AB , Halasa NB , Bline KE , Cameron MA , Schwartz SP , Walker TC , Irby K , Chiotos K , Nofziger RA , Mack EH , Smallcomb L , Bradford TT , Kamidani S , Tarquinio KM , Cvijanovich NZ , Schuster JE , Bhumbra SS , Levy ER , Hobbs CV , Cullimore ML , Coates BM , Heidemann SM , Gertz SJ , Kong M , Flori HR , Staat MA , Zinter MS , Hume JR , Chatani BM , Gaspers MG , Maamari M , Randolph AG , Patel MM , Boom JA . J Pediatric Infect Dis Soc 2022 12 (1) 29-35 |
BNT162b2 mRNA Vaccination Against COVID-19 is Associated with Decreased Likelihood of Multisystem Inflammatory Syndrome in U.S. Children Ages 5-18 Years.
Zambrano LD , Newhams MM , Olson SM , Halasa NB , Price AM , Orzel AO , Young CC , Boom JA , Sahni LC , Maddux AB , Bline KE , Kamidani S , Tarquinio KM , Chiotos K , Schuster JE , Cullimore ML , Heidemann SM , Hobbs CV , Nofziger RA , Pannaraj PS , Cameron MA , Walker TC , Schwartz SP , Michelson KN , Coates BM , Flori HR , Mack EH , Smallcomb L , Gertz SJ , Bhumbra SS , Bradford TT , Levy ER , Kong M , Irby K , Cvijanovich NZ , Zinter MS , Bowens C , Crandall H , Hume JR , Patel MM , Campbell AP , Randolph AG . Clin Infect Dis 2022 76 (3) e90-e100 |
Maternal Vaccination and Risk of Hospitalization for Covid-19 among Infants.
Halasa NB , Olson SM , Staat MA , Newhams MM , Price AM , Pannaraj PS , Boom JA , Sahni LC , Chiotos K , Cameron MA , Bline KE , Hobbs CV , Maddux AB , Coates BM , Michelson KN , Heidemann SM , Irby K , Nofziger RA , Mack EH , Smallcomb L , Schwartz SP , Walker TC , Gertz SJ , Schuster JE , Kamidani S , Tarquinio KM , Bhumbra SS , Maamari M , Hume JR , Crandall H , Levy ER , Zinter MS , Bradford TT , Flori HR , Cullimore ML , Kong M , Cvijanovich NZ , Gilboa SM , Polen KN , Campbell AP , Randolph AG , Patel MM . N Engl J Med 2022 387 (2) 109-119 |
BNT162b2 Protection against the Omicron Variant in Children and Adolescents.
Price AM , Olson SM , Newhams MM , Halasa NB , Boom JA , Sahni LC , Pannaraj PS , Irby K , Bline KE , Maddux AB , Nofziger RA , Cameron MA , Walker TC , Schwartz SP , Mack EH , Smallcomb L , Schuster JE , Hobbs CV , Kamidani S , Tarquinio KM , Bradford TT , Levy ER , Chiotos K , Bhumbra SS , Cvijanovich NZ , Heidemann SM , Cullimore ML , Gertz SJ , Coates BM , Staat MA , Zinter MS , Kong M , Chatani BM , Hume JR , Typpo KV , Maamari M , Flori HR , Tenforde MW , Zambrano LD , Campbell AP , Patel MM , Randolph AG . N Engl J Med 2022 386 (20) 1899-1909 |
Effectiveness of Maternal Vaccination with mRNA COVID-19 Vaccine During Pregnancy Against COVID-19-Associated Hospitalization in Infants Aged <6 Months - 17 States, July 2021-January 2022.
Halasa NB , Olson SM , Staat MA , Newhams MM , Price AM , Boom JA , Sahni LC , Cameron MA , Pannaraj PS , Bline KE , Bhumbra SS , Bradford TT , Chiotos K , Coates BM , Cullimore ML , Cvijanovich NZ , Flori HR , Gertz SJ , Heidemann SM , Hobbs CV , Hume JR , Irby K , Kamidani S , Kong M , Levy ER , Mack EH , Maddux AB , Michelson KN , Nofziger RA , Schuster JE , Schwartz SP , Smallcomb L , Tarquinio KM , Walker TC , Zinter MS , Gilboa SM , Polen KN , Campbell AP , Randolph AG , Patel MM . MMWR Morb Mortal Wkly Rep 2022 71 (7) 264-270 |
Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12-18 Years - United States, July-December 2021.
Zambrano LD , Newhams MM , Olson SM , Halasa NB , Price AM , Boom JA , Sahni LC , Kamidani S , Tarquinio KM , Maddux AB , Heidemann SM , Bhumbra SS , Bline KE , Nofziger RA , Hobbs CV , Bradford TT , Cvijanovich NZ , Irby K , Mack EH , Cullimore ML , Pannaraj PS , Kong M , Walker TC , Gertz SJ , Michelson KN , Cameron MA , Chiotos K , Maamari M , Schuster JE , Orzel AO , Patel MM , Campbell AP , Randolph AG . MMWR Morb Mortal Wkly Rep 2022 71 (2) 52-58 |
Effectiveness of BNT162b2 Vaccine against Critical Covid-19 in Adolescents.
Olson SM , Newhams MM , Halasa NB , Price AM , Boom JA , Sahni LC , Pannaraj PS , Irby K , Walker TC , Schwartz SP , Maddux AB , Mack EH , Bradford TT , Schuster JE , Nofziger RA , Cameron MA , Chiotos K , Cullimore ML , Gertz SJ , Levy ER , Kong M , Cvijanovich NZ , Staat MA , Kamidani S , Chatani BM , Bhumbra SS , Bline KE , Gaspers MG , Hobbs CV , Heidemann SM , Maamari M , Flori HR , Hume JR , Zinter MS , Michelson KN , Zambrano LD , Campbell AP , Patel MM , Randolph AG . N Engl J Med 2022 386 (8) 713-723 |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 06, 2024
- Content source:
- Powered by CDC PHGKB Infrastructure